- CA$40.14m
- CA$33.91m
- CA$37.42m
- 98
- 78
- 52
- 90
Annual balance sheet for Biorem, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 8.87 | 4.47 | 3.78 | 2.29 | 5.21 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7.6 | 10.1 | 12.2 | 15.1 | 14.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 18.3 | 16.2 | 17.8 | 20.6 | 24.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.42 | 1.15 | 1.02 | 1.99 | 2.02 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 22 | 19.2 | 20.7 | 24.1 | 28.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.82 | 13.2 | 12.9 | 13.9 | 15 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 8.43 | 17.2 | 16.2 | 17.4 | 17.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 13.5 | 1.96 | 4.52 | 6.72 | 10.6 |
| Total Liabilities & Shareholders' Equity | 22 | 19.2 | 20.7 | 24.1 | 28.5 |
| Total Common Shares Outstanding |